Re-Launching MeTeOR: Goals and Expectations For the Twelve Year Follow-Up
This is the final piece of a two-part series on the history and continuation of the MeTeOR (Meniscal Tear in Osteoarthritis Research) trial. In this installment, we spoke with OrACORe directors Jeffrey Katz, MD, Msc and Elena Losina, PhD about their expectations for MeTeOR's 12-year follow up, which set to begin in the spring of 2021. In the first installment…